| Literature DB >> 24422627 |
Dina A Proestou1, Patrick Flight, Denise Champlin, Diane Nacci.
Abstract
BACKGROUND: The most toxic aromatic hydrocarbon pollutants are categorized as dioxin-like compounds (DLCs) to which extreme tolerance has evolved independently and contemporaneously in (at least) four populations of Atlantic killifish (Fundulus heteroclitus). Surprisingly, the magnitude and phenotype of DLC tolerance is similar among these killifish populations that have adapted to varied, but highly aromatic hydrocarbon-contaminated urban/industrialized estuaries of the US Atlantic coast. Multiple tolerant and neighboring sensitive killifish populations were compared with the expectation that genetic loci associated with DLC tolerance would be revealed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24422627 PMCID: PMC4029433 DOI: 10.1186/1471-2148-14-7
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Killifish population locations and site characteristics
| NBH | New Bedford, MA | 41.6676 × 70.9159 | 0 | 56 | 4.6 | Tolerant |
| BI | Block Island, RI | 41.1818 × 71.5793 | 56 | | 1.4 | Sensitive |
| BP | Bridgeport, CT | 41.1570 × 73.2189 | 63 | 22 | 4.1 | Tolerant |
| FLAX | Flax Pond, NY | 40.9637 × 73.1342 | 85 | | 1.6 | Sensitive |
| NWK | Newark, NJ | 40.7006 × 74.1223 | 115 | 26 | 4.1 | Tolerant |
| SH | Sandy Hook, NJ | 40.4687 × 74.0113 | 141 | | 1.3 | Sensitive |
| ER | Portsmouth, VA | 36.8078 × 76.2945 | 547 | 55 | 5.3 | Tolerant |
| KC | Gloucester, VA | 37.3016 × 76.4226 | 492 | 1.4 | Sensitive |
Taken from Nacci et al. 2010. LC20 values represent the concentration of PCB126 resulting in 20% lethality of killifish embryos.
Figure 1Map of collection sites along the Eastern U.S. coast.
List of SNP containing candidate genes included in the population genetic analysis
| Aryl hydrocarbon receptor 1 | 1743961[uid] | transcription factor, response to xenobiotic stimulus | [ |
| Aryl hydrocarbon receptor 2 | 1743966[uid] | transcription factor, response to xenobiotic stimulus | [ |
| Aryl hydrocarbon receptor 2b | N/A | transcription factor, response to xenobiotic stimulus | Karchner & Hahn, unpublished; |
| Aryl hydrocarbon receptor repressor | 1743962[uid] | signal transducer, response to xenobiotic stimulus | [ |
| Atrial natriuretic peptide | 1743159[uid] | receptor binding, cardiac muscle hypertrophy in response to stress | [ |
| Aldehyde dehydrogenase family 9 member A1 | 1741825[uid] | oxidoreductase activity, retinoic acid metabolic process | [ |
| Cardiac myosin light chain-1 | 1741781[uid] | calcium ion binding, cardiac muscle tissue development | |
| Cathepsin E precursor | 1744072[uid] | endopeptidase, antigen processing | |
| Cathepsin F precursor | 1741927[uid] | cysteine-type peptidase activity | |
| Cathepsin Z precursor | 2476770[uid] | cysteine-type peptidase activity, angiogenesis | |
| Complement Component C3 | 1742328[uid] | protein binding, lipid binding, endopeptidase inhibitor, innate immune response, regulation of angiogenesis | [ |
| Cytochrome p450 1A | 2476796[uid] | oxidoreductase activity, dibenzo-p-dioxin catabolic process | [ |
| Cytochrome p450 3A30 | 1742582[uid] | oxidoreductase activity, response to xenobiotic stimulus | [ |
| Cytochrome B5 | 1743444[uid] | enzyme binding, heme binding, oxidation reduction process | [ |
| Estrogen Receptor alpha | 1743972[uid] | estrogen receptor activity, transcription factor binding, response to estradiol stimulus, regulation of retinoic acid receptor signalling pathway | [ |
| Estrogen Receptor beta a | 2301213[uid] | estrogen receptor activity, estrogen response element binding, response to estradiol stimulus, regulation of transcription factor activity | [ |
| Glyceraldehyde 3 phosphate dehydrogenase | 1742899[uid] | oxidation reduction process | |
| Hepcidin | 1744101[uid] | hormone activity, defense response | |
| Hepcidin 2 | N/A | | Karchner & Hahn, unpublished |
| Heatshock protein 90 beta | 1743580[uid] | protein binding, response to stress | |
| Plasma Kallikrein precursor | 1742469[uid] | peptidase activity, proteolysis, hemostasis | |
| Kallikrein | N/A | | Karchner & Hahn, unpublished |
| Myosin Light chain 2 | 1743984[uid] | actin monomer binding, heart development | [ |
| Myosin Light chain alkali, smooth muscle | 1743182[uid] | structural constituent of muscle, muscle contraction | |
| NADH [ubiquinone] dehydrogenase 1 alpha subcomplex subuint 4 | 1743852[uid] | electron transport chain | [ |
| Myosin regulatory light chain 3 | 1741657[uid] | calcium ion binding | |
| NADH dehydrogenase subunit 1 | 3014035[uid] | oxidoreductase activity | |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | 1743800[uid] | electron transport chain | [ |
| NADH dehydrogenase subunit 2 | 1742301[uid] | oxidoreductase activity | |
| NADH dehydrogenase subunit 3 | 1742764[uid] | oxidoreductase activity | |
| NADH dehydrogenase subunit 4 | 1741822[uid] | oxidoreductase activity | |
| NADH dehydrogenase subunit 6 | 3014152[uid] | oxidoreductase activity | |
| Platelet Coagulation Factor XI | 3014242[uid] | peptidase activity, proteolysis, hemostasis | [ |
| Retinoic Acid Receptor Responder Protein 1 | 1743266[uid] | negative regulation of cell proliferation | |
| Retinoic Acid Receptor Responder Protein 3 | 1741754[uid] | negative regulation of cell proliferation | |
| Rho-class Glutathione S-Transferase | 1743333[uid] | transferase activity | [ |
| Serine Protease Inhibitor | N/A | negative regulation of endopeptidase activity | Karchner & Hahn, unpublished |
| TBT Binding Protein | 1741555[uid] | response to xenobiotic stimulus | [ |
| Thioredoxin | 1743303[uid] | protein binding, oxidoreductase activity | [ |
| Translation Initiation Factor 2 | 1744423[uid] | ligand-dependent nuclear receptor binding, estrogen receptor binding, retinoic acid receptor binding, signal transduction | |
| Telethonin (Titin cap protein) | 1743784[uid] | heart development, cardiac muscle contraction, sarcomere organization, response to stress | [ |
| Cardiac Troponin T2 | 1742146[uid] | actin binding, tropomyosin binding, troponin binding, cardiac muscle morphogenesis, sarcomere organization, muscle filament sliding | [ |
| Ubiquitin A-52 residue ribosomal protein fusion product 1 | 1744070[uid] | structural constituent of ribosome, translation |
Note: Potential involvement of each gene in toxic DLC response was demonstrated in citations listed in ‘Reference’ column.
N/A = not available.
Genetic parameters for sampled populations
| BI | 65.31 (49) | 0.15 | 0.15 | 71.88 | 0.042 | 0.16 |
| NBH | 53.19 (47) | 0.14 | 0.16 | 76.00 | 0.171* | 0.20 |
| BP | 64.58 (48) | 0.15 | 0.15 | 93.55 | 0.001 | 0.16 |
| FLAX | 61.22 (49) | 0.16 | 0.17 | 90.00 | 0.059 | 0.19 |
| SH | 73.33 (45) | 0.16 | 0.21 | 78.79 | 0.240* | 0.19 |
| NWK | 64.58 (48) | 0.15 | 0.16 | 80.65 | 0.031 | 0.19 |
| ER | 51.02 (49) | 0.12 | 0.15 | 60.00 | 0.108* | 0.21 |
| KC | 57.14 (49) | 0.14 | 0.17 | 82.14 | 0.122* | 0.22 |
| Mean | 61.30 | 0.15 | 0.17 | 79.12 | 0.097 | 0.19 |
| Standard Deviation | 7.28 | 0.01 | 0.02 | 10.46 | 0.080 | 0.02 |
PO = number of polymorphic loci/number of usable loci (in parentheses); HO = sum of observed heterozygosity for each usable locus/number of usable loci; HE = sum of expected heterozygosity for each usable locus/number of usable loci; % HWE = number of loci in Hardy-Weinberg equilibrium/number of polymorphic loci; FIS = population specific fixation index; MAF = average Minor Allele Frequency, calculated for polymorphic loci only. *p ≤ 0.05 based on 10,000 permutations.
Figure 2Pairwise Fcomparisons demonstrating genetic differences between all populations. FSTs calculated with data from all SNP loci. Values below the diagonal represent genetic distances and values above the diagonal represent significance level. BI = Block Island, RI, NBH = New Bedford Harbor, MA, BP = Bridgeport, CT, FLAX = Flax Pond, NY, SH = Sandy Hook, NJ, NWK = Newark, NJ, ER = Elizabeth River, VA, KC = Kings Creek, VA.
T-test results
| PO | 0.64 (0.07) | 0.58 (0.07) | 0.28 |
| HO | 0.15 (0.01) | 0.14 (0.01) | 0.23 |
| HE | 0.18 (0.03) | 0.16 (0.01) | 0.18 |
| MAF | 0.15 (0.02) | 0.15 (0.01) | 1.0 |
Comparison of mean genetic diversity measures between DLC-sensitive and DLC-tolerant F. heteroclitus populations. Standard deviations are in parentheses. PO = average percentage of polymorphic loci within groups; HO = average observed heterozygosity within groups; HE = average expected heterozygosity within groups; MAF = average minor allele frequency within groups. Results are based on genotype information gathered from 36/37 individuals per population at 59 SNP loci representing 42 genes.
AMOVA results (populations grouped according to DLC sensitivity); data from all loci, CYP1A, and AHR2
| | | | | |
| Among Groups | 1 | 31.573 | −0.19211 (Va) | −4.38 |
| Among Pops w/in Groups | 6 | 528.228 | 1.15127 (Vb) | 26.27 |
| W/in Pops | 580 | 1985.789 | 3.42377 (Vc) | 78.12 |
| Total | 587 | 2545.590 | 4.38293 | |
| | | | | |
| Among Groups | 1 | 2.726 | −0.01613 (Va) | −6.52 |
| Among Pops w/in Groups | 6 | 44.501 | 0.09971 (Vb) | 40.32 |
| W/in Pops | 574 | 93.977 | 0.16372 (Vc) | 66.20 |
| Total | 581 | 141.204 | 0.24730 | |
| | | | | |
| Among Groups | 1 | 12.822 | 0.03671 (Va) | 13.50 |
| Among Pops w/in Groups | 6 | 13.271 | 0.02775 (Vb) | 10.20 |
| W/in Pops | 570 | 118.296 | 0.20754 (Vc) | 76.30 |
| Total | 577 | 144.389 | 0.27200 |
Figure 3Reduced major axis regression of genetic distance and geographic distance. Genetic distance = pairwise FST; Geographic (latitudinal) distance in meters. (A) All populations (B) DLC-sensitive populations only (C) DLC-tolerant populations only.
Single locus F values demonstrating high differentiation among population pairs
| | ||||
|---|---|---|---|---|
| Aryl hydrocarbon receptor 1_1530 | −0.00349 | |||
| Aryl hydrocarbon receptor 1_161 | 0.00028 | 0.00929 | N/A | |
| Aryl hydrocarbon receptor 1_2289 | N/A | −0.00376 | N/A | |
| Aryl hydrocarbon receptor 1_948 | −0.0137 | −0.01388 | N/A | |
| Aryl hydrocarbon receptor 2_1929 | 0.04692 | |||
| Aryl hydrocarbon receptor 2_792 | N/A | 0.00417 | N/A | |
| Cathepsin F_653 | −0.0137 | −0.01271 | 0.03401 | |
| Cathepsin Z_624 | 0.04241 | −0.00759 | −0.00325 | |
| Cytochrome P450 1A_2140 | ||||
| Cytochrome P450 3A_1166 | −0.01332 | −0.00179 | −0.01449 | |
| Hepcidin2_399 | 0.06457 | 0.00719 | 0.04197 | |
| Heat shock protein 90_775 | 0.09438 | N/A | 0.02932 | |
| NADH ubiquinone oxidoreductase MLRQ subunit_363 | −0.01268 | −0.01516 | ||
| Myosin regulatory light chain 3_372 | −0.00843 | −0.01529 | 0.0674 | |
| NADH dehydrogenase subunit 4_347 | 0.0137 | N/A | N/A | |
| NADH dehydrogenase subunit 4_586 | 0.01315 | N/A | 0.01408 | |
| NADH dehydrogenase subunit 4_669 | 0.01259 | N/A | N/A | |
| NADH dehydrogenase subunit 6_787 | 0.01486 | N/A | N/A | |
| Serine protease inhibitor_938 | 0.00078 | N/A | 0.03176 | |
| TBT binding protein_635 | −0.00786 | −0.00228 | N/A | |
| Thioredoxin_582 | 0.01625 | −0.00785 | 0.1248 | |
FST values for highly differentiated loci across all four DLC-sensitive/-tolerant population pairs. FSTs were calculated using the locus by locus AMOVA function in Arlequin v. 3.5. Values exceeding an FST threshold of 0.1 are noted in bold and are significant at p < 0.05. Comparisons that were not made because the markers were monomorphic in some populations are noted as N/A. BI = Block Island, NBH = New Bedford Harbor, Flax = Flax Pond, BP = Bridgeport, SH = Sandy Hook, NWK = Newark, KC = Kings Creek, and ER = Elizabeth River.
Figure 4Results of an Fmodeling approach to detect loci under selection. Empirical FST values have been plotted against heterozygosity for each pairing of DLC-sensitive and DLC-tolerant sites (A) and for the pooled DLC-sensitive/-tolerant comparison (B). Gray lines represent the 95th percentile and black, dotted lines represent the 99th percentile. Red data points indicate outlier SNPs with respect to the FST null distribution.
Minor allele frequencies of SNP markers calculated for each population
| | | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aglobin_89 | A/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AHR1_1530 | C/ | 0.08 | 0.62 | 0.23 | 0.03 | 0.26 | 0.2 | 0.44 | 0.19 |
| AHR1_161 | C/ | 0.14 | 0.5 | 0.04 | 0.01 | 0.03 | 0.08 | 0 | 0 |
| AHR1_2289 | G/ | 0.07 | 0.64 | 0 | 0 | 0.03 | 0.05 | 0 | 0 |
| AHR1_948 | C/ | 0.07 | 0.49 | 0.01 | 0.01 | 0.03 | 0.03 | 0 | 0 |
| 0.15 | 0.51 | 0.27 | 0.59 | 0.49 | 0.67 | 0.57 | 0.87 | ||
| AHR2_792 | C/ | 0.07 | 0.5 | 0 | 0 | 0.03 | 0.07 | 0 | 0 |
| AHR2B_992 | 0 | 0 | 0.05 | 0.07 | 0.05 | 0.01 | 0 | 0 | |
| AHRR_1095 | C/ | 0 | 0 | 0.11 | 0.05 | 0 | 0 | 0 | 0.06 |
| AHRR_1299 | C/ | 0 | 0 | 0.15 | 0.05 | 0 | 0 | 0.01 | 0.06 |
| ANP_521 | C/ | 0.24 | 0.44 | 0.7 | 0.41 | 0.29 | 0.23 | 0.38 | 0.28 |
| BAD_213 | G/ | 0.15 | 0.28 | 0.24 | 0.27 | 0.21 | 0.28 | 0.06 | 0.07 |
| Bglobin_193 | C/ | 0 | 0 | 0 | 0.01 | 0.03 | 0.01 | 0.1 | 0.07 |
| Cardiac_MLC1_250 | C/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CathE_730 | A/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CathF_653 | A/ | 0.2 | 0 | 0.09 | 0.09 | 0.21 | 0.2 | 0.14 | 0.26 |
| CathZ_624 | G/ | 0.5 | 0.15 | 0.19 | 0.34 | 0.43 | 0.38 | 0.31 | 0.38 |
| CC3_571 | A/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0.73 | 0.24 | 0.57 | 0.11 | 0.42 | 0.11 | 0.2 | 0.93 | ||
| CYP3A_1166 | 0.78 | 0.19 | 0.42 | 0.43 | 0.21 | 0.28 | 0.06 | 0.06 | |
| CytB5_626 | 0.01 | 0 | 0.01 | 0.01 | 0.06 | 0.05 | 0.07 | 0 | |
| ERa_1497 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| ERba_1373 | 0.19 | 0.25 | 0.51 | 0.38 | 0.68 | 0.47 | 0.04 | 0.03 | |
| GP3D_530 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | |
| Hepcidin_69 | C/ | 0.11 | 0.08 | 0.07 | 0.16 | 0.01 | 0.03 | 0 | 0 |
| Hepcidin2_399 | A/ | 0.12 | 0.37 | 0.26 | 0.11 | 0.39 | 0.49 | 0.68 | 0.82 |
| HSP90_775 | A/ | 0.01 | 0.14 | 0 | 0 | 0.04 | 0 | 0.14 | 0 |
| Kallikrein_502 | G/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| KallikreinS_309 | A/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MLC2_436 | 0 | 0 | 0.07 | 0.05 | 0.14 | 0.07 | 0.19 | 0.33 | |
| MLC2_535 | A/ | 0 | 0 | 0.03 | 0.01 | 0.07 | 0 | 0.32 | 0.35 |
| MLCA_577 | 0.09 | 0.03 | 0.08 | 0.08 | 0.26 | 0.09 | 0.03 | 0.01 | |
| MLRQ_363 | A/ | 0.46 | 0.07 | 0.11 | 0.09 | 0.42 | 0.17 | 0.7 | 0.7 |
| MRCL3_372 | 0.27 | 0.14 | 0.22 | 0.18 | 0.05 | 0.04 | 0.17 | 0.04 | |
| NADH10_107 | A/ | 0.19 | 0.03 | 0.15 | 0.24 | 0.14 | 0.05 | 0.13 | 0.31 |
| NADH10_439 | 0.31 | 0.28 | 0.23 | 0.19 | 0.25 | 0.18 | 0.51 | 0.64 | |
| NADH2_349 | 0 | 0 | 0.11 | 0.05 | 0 | 0.05 | 0.03 | 0 | |
| NADH3_165 | C/ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NADH4_347 | C/ | 0.03 | 0 | 0 | 0 | 0.26 | 0 | 1 | 1 |
| NADH4_586 | A/ | 0.03 | 0 | 0 | 0 | 0.27 | 0.05 | 0.03 | 0 |
| NADH4_669 | G/ | 0.03 | 0 | 0 | 0 | 0.28 | 0 | 1 | 1 |
| NADH6_787 | 0.08 | 0.05 | 0 | 0 | 0.28 | 0 | 1 | 1 | |
| PCFXI_511 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| RARR1_759 | A/ | 0.08 | 0.14 | 0.22 | 0.21 | 0.52 | 0.35 | 0.7 | 0.39 |
| RGST_397 | A/ | 0.1 | 0.12 | 0.19 | 0.3 | 0.14 | 0.19 | 0.52 | 0.64 |
| SPI_938 | 0.04 | 0.08 | 0 | 0 | 0.06 | 0 | 0.27 | 0.08 | |
| TBTbp_635 | 0.03 | 0.18 | 0.04 | 0.02 | 0.02 | 0 | 0 | 0 | |
| Thioredoxin_582 | 0.3 | 0.04 | 0.53 | 0.65 | 0.47 | 0.5 | 0.75 | 0.49 | |
| TIF2_727 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.11 | 0.06 | |
| Titin_478 | 0.19 | 0.1 | 0.46 | 0.26 | 0.42 | 0.3 | 0.66 | 0.64 | |
| TroponinT2_653 | 0.3 | 0.19 | 0.28 | 0.19 | 0.38 | 0.4 | 0.17 | 0.23 | |
Zero values indicate populations where the SNP marker was monomorphic. Minor alleles in bold.
Figure 5Shifts in minor allele frequencies across populations for (A) AHR2 and (B) CYP1A. Populations are arranged with respect to geographical region. Corresponding log LC20 values measured in response to PCB126 for each population (Nacci et al. 2010) are also noted.